8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)
Published . Updated .
8-K - ANAVEX LIFE SCIENCES filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
Directly affected
- AVXL Anavex Life Sciences-50.6% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Anavex Life Sciences belongs to, so it often moves with news about it.
- AMGN Amgen+18.4% 30d
Amgen is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+16.6% 30d
Gilead Sciences is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+28.2% 30d
Moderna is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-17.4% 17d
argenx SE is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| AVXL | +13.54% | +13.54% | base | after close | after close | after close | after close |
| XLV | -2.95% | -0.31% | base | after close | after close | after close | after close |
| AMGN | -3.75% | -1.04% | base | after close | after close | after close | after close |
| GILD | -6.65% | -2.82% | base | after close | after close | after close | after close |
| MRNA | -5.90% | +0.84% | base | after close | after close | after close | after close |
| ARGX | +0.87% | +2.64% | base | after close | after close | after close | after close |
| RVMD | -1.02% | +1.20% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-11-02 AccNo: 0001731122-26-001392 Size: 206 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events…
Source: sec-edgar
Price since this story was published: Anavex Life Sciences (AVXL)
| Company | When | Move | Status |
|---|---|---|---|
| Amgen (AMGN) | three days earlier | -1.04% | final price |
| Amgen (AMGN) | five days earlier | -3.75% | final price |
| Argenx Se (ARGX) | three days earlier | +2.64% | final price |
| Argenx Se (ARGX) | five days earlier | +0.87% | final price |
| Anavex Life Sciences (AVXL) | three days earlier | +13.54% | final price |
| Anavex Life Sciences (AVXL) | five days earlier | +13.54% | final price |
| Gilead Sciences (GILD) | three days earlier | -2.82% | final price |
| Gilead Sciences (GILD) | five days earlier | -6.65% | final price |
| Moderna (MRNA) | three days earlier | +0.84% | final price |
| Moderna (MRNA) | five days earlier | -5.90% | final price |
| Revolution Medicines (RVMD) | three days earlier | +1.20% | final price |
| Revolution Medicines (RVMD) | five days earlier | -1.02% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -0.31% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -2.95% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 41 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 68 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 82 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 84 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 66 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)”
Companies carried with this story
- AVXL Anavex Life Sciences
For “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer),” Anavex Life Sciences (AVXL) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> AVXL
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer).” Reason on file: Health Care Select Sector SPDR holds the health sector that Anavex Life Sciences belongs to, so it often moves with news about it
- AMGN Amgen
For “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer),” Amgen (AMGN) is linked, with no stored direction, medium confidence. Reason on file: Amgen is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news
- GILD Gilead Sciences
For “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer),” Gilead Sciences (GILD) is linked, with no stored direction, medium confidence. Reason on file: Gilead Sciences is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news
- MRNA Moderna
In “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer),” Moderna (MRNA) is linked, with no stored direction, medium confidence. Reason on file: Moderna is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news
- ARGX Argenx Se
In “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer),” Argenx Se (ARGX) is linked, with no stored direction, medium confidence. Reason on file: argenx SE is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news
- RVMD Revolution Medicines
Revolution Medicines (RVMD) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer).” Reason on file: Revolution Medicines is a peer of Anavex Life Sciences in biological products, (no diagnostic substances); rivals often move on the same news
How “8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)” reaches Anavex Life Sciences (AVXL)
“8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)” (2 Nov 2026) reaches Anavex Life Sciences (AVXL) through this story.
Anavex Life Sciences (AVXL) is on the page because SEC 8-K filing -> direct issuer disclosure -> AVXL
Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR holds the health sector that Anavex Life Sciences belongs to, so it often moves with news about it
The price range for Anavex Life Sciences (AVXL), and the dates in the story
AMGN traded between 396.21 and 475.42 across 20 sessions. The latest close on file is 466.11. AVXL traded between 1.15 and 1.81 across 20 sessions. The latest close on file is 1.18.
A simple score for Anavex Life Sciences (AVXL)
46 out of 100
“8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.